Genetic selection of volunteers and concomitant dose adjustment leads to comparable hydralazine/valproate exposure-Reference-Cited by-同舟云学术

Genetic selection of volunteers and concomitant dose adjustment leads to comparable hydralazine/valproate exposure

Published:2014-04-04 Issue:4 Volume:39 Page:368-375
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Garcés-Eisele S. J.¹²,Cedillo-Carvallo B.³,Reyes-Núñez V.¹,Estrada-Marín L.³,Vázquez-Pérez R.³,Juárez-Calderón M.³,Guzmán-García M. O.¹,Dueñas-González A.⁴,Ruiz-Argüelles A.¹³⁵

Affiliation:

1. Clínica Ruiz Laboratorios; Puebla México

2. Universidad Popular Autónoma del Estado de Puebla; Puebla México

3. Laboratorios Clínicos de Puebla de Bioequivalencia; Puebla México

4. Unidad de Investigación Biomédica en Cáncer; Instituto Nacional de Cancerología/Instituto de Investigaciones Biomédicas; UNAM; México City México

5. Universidad de las Américas; Puebla México

Funder

Alpharma S.A. de C.V., Mexico City Sponsors

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12155/fullpdf

Reference57 articles.

1. Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy;Jakopovic;Front Oncol,2013

2. The fundamental role of epigenetic events in cancer;Jones;Nat Rev Genet,2002

3. Cancer genes and the pathways they control;Vogelstein;Nat Med,2004

4. The epigenetic progenitor origin of human cancer;Feinberg;Nat Rev Genet,2006

5. Epigenetics in cancer;Sharma;Carcinogenesis,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The inhibitory and transcriptional effects of the epigenetic repurposed drugs hydralazine and valproate in lymphoma cells;American Journal of Cancer Research;2024

2. Synthesis, structural characterization and DNA binding properties of phthalazinylhydrazone-furan and triazolophthalazine-ferrocene compounds;Journal of Molecular Structure;2023-02

3. Discovery of anticancer therapeutics: Computational chemistry and Artificial Intelligence-assisted approach;Computational Methods in Drug Discovery and Repurposing for Cancer Therapy;2023

4. A review on the clinical pharmacokinetics of hydralazine;Expert Opinion on Drug Metabolism & Toxicology;2022-09-27

5. Pharmacogenomics Informs Cardiovascular Pharmacotherapy;Methods in Molecular Biology;2022